The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.János L. Tanyi, Gordon B. Mills, Andrew J. Morris et al.|PubMed|2003Cited by 143
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaMariela Sivina, Jan A. Burger, Ruth LaPushin et al.|Blood|2010Cited by 126
Identification of Tissue- and Cancer-Selective Promoters for the Introduction of Genes into Human Ovarian Cancer CellsJános L. Tanyi, Judith K. Wolf, Gordon B. Mills et al.|Gynecologic Oncology|2002Cited by 21